Braxia Scientific Cash Flow Statement

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Net Income	-9.64	-13.14	-12.13	-88.83	-3.3
Depreciation & Amortization	0.37	0.57	0.02	0.02	-
Asset Writedown & Restructuring Costs	5.47	5.47	5.28	-	-
Loss (Gain) on Equity Investments	0.03	-0.02	0	-	-
Stock-Based Compensation	0.13	0.86	2.42	3.1	3.22
Provision & Write-off of Bad Debts	-	-	0.02	0.13	-
Other Operating Activities	-0.09	0.16	-0.28	77.78	-
Change in Other Net Operating Assets	1.15	-1.3	0.15	2.37	0.03
Operating Cash Flow	-2.58	-7.4	-4.52	-5.06	-0.05
Capital Expenditures	-0.06	-0.83	-0.03	-0.02	-
Cash Acquisitions	-	0	-	-1.28	-
Sale (Purchase) of Intangibles	0.02	-0.08	-	-	-
Investment in Securities	-	0.01	-0.04	-	-
Other Investing Activities	0.03	-0.24	-0.55	-	-
Investing Cash Flow	-0.02	-1.13	-0.61	-1.31	-
Long-Term Debt Issued	-	-	-	0.06	-
Total Debt Issued	-	-	-	0.06	0.09
Long-Term Debt Repaid	-	-0.03	-0.01	-0.02	-
Net Debt Issued (Repaid)	-0.07	-0.03	-0.01	0.04	0.09
Issuance of Common Stock	1.26	1.26	2.72	13.73	5.2
Other Financing Activities	-	-	-	0.64	-
Financing Cash Flow	1.19	1.24	2.7	14.41	5.28
Foreign Exchange Rate Adjustments	0.04	0.08	-	-	-
Net Cash Flow	-1.36	-7.22	-2.42	8.05	5.23
Free Cash Flow	-2.65	-8.23	-4.54	-5.08	-0.05
Free Cash Flow Margin	-119.78%	-436.60%	-305.52%	-503.59%	-
Free Cash Flow Per Share	-0.01	-0.04	-0.03	-0.03	-3.44
Levered Free Cash Flow	-0.97	-4.08	-2.77	-1.31	-
Unlevered Free Cash Flow	-0.93	-4.07	-2.77	-1.31	-
Change in Net Working Capital	-1.1	0.09	0.73	-2.18	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.